Acquisition of BlueRock by multinational Pharmaceutical firm for US$1billion
An announcement was made by the multinational pharma firm ‘Bayer AG’ that it has gotten complete acquisition of BlueRock Therapeutics, valuing the biotech company along with offices situated in Toronto at nearly 1 billion dollars. Already Bayer had the ownership…